CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

Invenio Imaging Announces Completion of Enrollment in Landmark Study of AI-Based Image Analysis for Lung Cancer

Trial StartNIO Lung Cancer RevealPositive
AI Analysis

Summary

Invenio Imaging announced completion of patient enrollment in the ON-SITE pivotal study evaluating NIO Lung Cancer Reveal, an AI-based image analysis tool for lung cancer diagnosis.

Clinical Trial Data

Phase

pivotal

Outcome Details

Enrollment completion in ON-SITE pivotal study

Importance:5/10
Sentiment:
0.50
AIimage analysislung cancerenrollment completionpivotal study

Read the original article

Published by PR Newswire Clinical Trials on August 3, 2026 8:59 AM

Read Original